Vitamin D Supplementation in Physical Performance

October 27, 2017 updated by: Tirang R. Neyestani, Ph.D., National Nutrition and Food Technology Institute

Efficacy of Vitamin D Supplementation in Physical Performance of Iranian Elite Athletes

This study was performed to evaluate the efficacy of weekly vitamin D supplementation on athletic performance in Iranian athletes

Study Overview

Status

Completed

Conditions

Detailed Description

Seventy subjects were enrolled in the study. The athletes were randomly divided into two groups: vitamin D supplement (D; received 50,000 IU of vitamin D supplement weekly) and control (P, received a placebo weekly). Duration of the study was eight weeks. Anthropometric, dietary, athletic performance and biochemical evaluations were performed for all subjects in the beginning and in the end of the intervention period.

Study Type

Interventional

Enrollment (Actual)

70

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Tehran
      • Tehrān, Tehran, Iran, Islamic Republic of
        • National Nutrition and Food Technology Research Institute

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 30 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • healthy
  • professional athletes

Exclusion Criteria:

  • receiving vitamin D supplement in past 3 months

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: vitamin D supplement
D
D; received 50,000 IU of vitamin D supplement weekly
Other Names:
  • D
Placebo Comparator: control
P
placebo
Other Names:
  • P

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes from baseline serum 25-hydroxy vitamin D at eight weeks
Time Frame: 8 weeks
nmol/L
8 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes from baseline Truncal Fat at eight weeks
Time Frame: 8 weeks
percent
8 weeks
Changes from baseline visceral fat at eight weeks
Time Frame: 8 weeks
percent
8 weeks
Changes from Strength leg press at 8 weeks
Time Frame: 8 weeks
percent
8 weeks
Changes from Ergojump at 8 weeks
Time Frame: 8 weeks
percent
8 weeks
Changes from baseline Vertical jump at 8 weeks
Time Frame: 8 weeks
percent
8 weeks
Change from baseline Agility at 8 weeks
Time Frame: 8 weeks
percent
8 weeks
changes from Speed at 8 weeks
Time Frame: 8 weeks
percent
8 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Tirang R. Neyestani, PhD, Laboratory of Nutrition Research, National Nutrition and Food Technology Research Institute (NNFTRI) and Faculty of Nutrition Science and Food Technology, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 1, 2017

Primary Completion (Actual)

September 1, 2017

Study Completion (Actual)

September 30, 2017

Study Registration Dates

First Submitted

October 20, 2017

First Submitted That Met QC Criteria

October 27, 2017

First Posted (Actual)

October 30, 2017

Study Record Updates

Last Update Posted (Actual)

October 30, 2017

Last Update Submitted That Met QC Criteria

October 27, 2017

Last Verified

October 1, 2017

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy

Clinical Trials on Placebo

3
Subscribe